Table 2 Clinical parameters in patients with small, normal-sized and enlarged spleens, respectively, with clinically mild or severe Covid-19 infection
Clinical parameter | Normal-sized spleen, clinically mild disease | Normal-sized spleen, clinically severe disease | Small spleen, clinically severe disease | Splenomegaly, clinically mild disease | Splenomegaly, clinically severe disease |
|---|---|---|---|---|---|
Splenic size | n = 250 (49%) | n = 9 (2%) | n = 250 (49%) | ||
Clinically mild disease, O2 Sat ≥ 93% | n = 192 (76%) | n = 184 (74%) | |||
Clinically severe disease, O2 Sat < 93% | n = 58 (24%) | n = 9 (100%) | n = 66 (26%) | ||
Pathological lung volume | 97% of patients → 0–20% (score 1) | All patients → 23–71% (score 1–3) | All patients → 34–55% (score 2 & 3) | 97% of patients → 0–20% (score 1) | All patients → 27–73% (Score 2 & 3) |
Splenic volume at follow-up CT | 100% unchanged | 100% unchanged | 100% unchanged | 87% unchanged, 13% regression | 75% unchanged, 25% progression |